JP2024536862A5 - - Google Patents
Info
- Publication number
- JP2024536862A5 JP2024536862A5 JP2024518802A JP2024518802A JP2024536862A5 JP 2024536862 A5 JP2024536862 A5 JP 2024536862A5 JP 2024518802 A JP2024518802 A JP 2024518802A JP 2024518802 A JP2024518802 A JP 2024518802A JP 2024536862 A5 JP2024536862 A5 JP 2024536862A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- substituted
- pharmaceutically acceptable
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163248569P | 2021-09-27 | 2021-09-27 | |
| US63/248,569 | 2021-09-27 | ||
| PCT/US2022/077003 WO2023049888A1 (en) | 2021-09-27 | 2022-09-26 | Benzimidazoles as modulators of il-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536862A JP2024536862A (ja) | 2024-10-08 |
| JP2024536862A5 true JP2024536862A5 (enExample) | 2025-10-01 |
Family
ID=83880137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518802A Pending JP2024536862A (ja) | 2021-09-27 | 2022-09-26 | Ｉｌ－１７の調節因子としてのベンズイミダゾール |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240376085A1 (enExample) |
| EP (1) | EP4408530A1 (enExample) |
| JP (1) | JP2024536862A (enExample) |
| CN (1) | CN118119613A (enExample) |
| CA (1) | CA3233410A1 (enExample) |
| WO (1) | WO2023049888A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202430165A (zh) | 2022-12-02 | 2024-08-01 | 丹麥商理奧藥品公司 | Il-17之小分子調節劑 |
| WO2025247285A1 (zh) * | 2024-05-28 | 2025-12-04 | 西藏海思科制药有限公司 | 一种可抑制il-17a的杂环化合物制备及其用途 |
| WO2026012492A1 (en) * | 2024-07-12 | 2026-01-15 | Anew Therapeutics Pte. Ltd. | Heterocyclic compounds as il-17 inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11472794B2 (en) * | 2018-01-15 | 2022-10-18 | UCB Biopharma SRL | Fused imidazole derivatives as IL-17 modulators |
| CN110511213B (zh) * | 2018-05-22 | 2021-10-19 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
-
2022
- 2022-09-26 CN CN202280065021.4A patent/CN118119613A/zh active Pending
- 2022-09-26 WO PCT/US2022/077003 patent/WO2023049888A1/en not_active Ceased
- 2022-09-26 EP EP22790423.2A patent/EP4408530A1/en active Pending
- 2022-09-26 US US18/693,310 patent/US20240376085A1/en active Pending
- 2022-09-26 JP JP2024518802A patent/JP2024536862A/ja active Pending
- 2022-09-26 CA CA3233410A patent/CA3233410A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024536862A5 (enExample) | ||
| JP2024536869A5 (enExample) | ||
| JP2024050527A5 (enExample) | ||
| JP2024536868A5 (enExample) | ||
| JP2023524018A5 (enExample) | ||
| JP2024536863A5 (enExample) | ||
| JP2023500328A5 (enExample) | ||
| JP2014037426A5 (enExample) | ||
| TW202208367A (zh) | 作為ｉｌ－１７調節劑之咪唑并嗒類 | |
| JP2021535174A5 (enExample) | ||
| JP2023515617A5 (enExample) | ||
| JP2018520161A5 (enExample) | ||
| IL311751A (en) | IL-17 imidazopyridazine inhibitory compounds | |
| JP2017518959A5 (enExample) | ||
| JP2009534406A5 (enExample) | ||
| JP2021535177A5 (enExample) | ||
| JP2010540508A5 (enExample) | ||
| JP2021534106A5 (enExample) | ||
| RU2007101236A (ru) | Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей | |
| JP2004307440A (ja) | ２−アミノ‐１，３‐プロパンジオール誘導体とその付加塩 | |
| JP2023512664A5 (enExample) | ||
| JP2022526553A5 (enExample) | ||
| JP2025160251A5 (enExample) | ||
| JP2009500409A (ja) | 痛みを処置するためのα２アドレナリン作動剤 | |
| JP2023511152A5 (enExample) |